NEW YORK, May 6, 2019 /PRNewswire/ — Arsenal Capital Partners (“Arsenal”), a leading specialized private equity firm that invests in middle-market healthcare and specialty industrials companies, announced today the acquisition of Hopebridge, LLC (“Hopebridge”), a center-based provider of behavioral health services for children affected by autism spectrum disorder. The terms of the acquisition were not disclosed.
Founded in 2005, Hopebridge provides personalized, comprehensive outpatient Applied Behavior Analysis (“ABA”), occupational, speech, and feeding therapies for children with autism spectrum disorder or affected by other behavioral, physical, social, communication, and sensory challenges.
Dennis May, the CEO of Hopebridge, said, “We are excited to be partnering with the Arsenal team, which has an extensive history of investing in the healthcare space. We are confident that this strategic relationship will further enhance Hopebridge’s ability to make investments in its platform to serve the growing need for autism treatment services and provide the children and families with the care, support, and hope they deserve.”
BG Porter, an Operating Partner of Arsenal and recently named Chair of Hopebridge’s board, added, “Arsenal and its portfolio companies are committed to improving the efficiency and efficacy of the healthcare industry and thereby patient outcomes. We are excited to work with Dennis and his team to continue to expand access to treatment and services for those affected by autism and support the company through its next phase of growth.”
Cain Brothers, a division of KeyBanc Capital Markets, acted as a financial advisor, and Ropes & Gray LLP acted as a legal advisor to Arsenal. Harris Williams acted as a financial advisor, and DLA Piper LLP acted as a legal advisor to Hopebridge.
This article originally appeared in an article in PR Newswire.